Original Research Session

The Medicalization of Female Sexual Desire Disorder: Restricting Sexual Normalcy Under the Guise of Equality and
Empowerment (#156)

Presenter: Molly Moreau, MA
Saturday, June 15, 2019
We appreciate your help in evaluating this session. Please indicate your rating of the presentation in the categories below by selecting the appropriate number, using a scale of 1 (low) through 5 (high).

Question Title

* 1. OBJECTIVES
This session met the stated objectives of:

  Strongly disagree
1
Disagree
2
Neither agree or disagree
3
Agree
4
Strongly agree
5
thoughtfully critique Flibanserin and other sexual pharmaceuticals aiming to augment female sexual desire.

Question Title

* 2. Speaker(s)

  1 2 3 4 5
Knowledgeable in content areas
Content consistent with objectives
Clarified content in response to questions

Question Title

* 3. Content

  Strongly disagree
1
Disagree
2
Neither agree or disagree
3
Agree
4
Strongly agree
5
Appropriate for intended audience
Consistent with stated objectives

Question Title

* 4. Teaching Methods

  1 2 3 4 5
Visual aids, handouts, and oral presentations clarified content
Teaching methods were appropriate for subject matter

Question Title

* 5. Relevancy

  1 2 3 4 5
Information could be applied to practice
Information could contribute to achieving personal, professional goal

Question Title

* 6. How much did you learn as a result of this CE program?

Question Title

* 7. How useful was the content of this CE program for your practice or other professional development?

Question Title

* 8. This workshop enhanced my professional expertise.

Question Title

* 9. I would recommend this workshop to others.

T